ADD ANI AS A TRUSTED SOURCE
Add ANI as a Trusted Source for Reliable Information
Menu
SEC to take decision on antiviral Covid pill today
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject...
SII seeks approval for Covishield vaccine as booster dose...
New Delhi [India], December 2 (ANI): The Serum Institute of India (SII) has sought India's drug regulator's...
EU drug regulator to add brain blood clot warning to...
Brussels [Belgium], November 11 (ANI/Sputnik): The EU drug regulator advised on Thursday listing blood clots in the...
Biological E gets drug regulator's approval to conduct phase...
New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to...
Will take another 4-5 months to publish phase 3 trials data...
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm...
US approves third dose of COVID vaccine for people with weak...
Washington [US] August 13 (ANI/FENA): US drug regulators say transplant recipients and others with severely weakened...
Zydus Cadila submits additional data to DCGI for its COVID-19...
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to...
Granules India subsidiary clears USFDA audit
Hyderabad (Telangana) [India], July 21 (ANI): The drug maker Granules India on Wednesday announced that its US-based...
Emergency approval for Zydus Cadila to take few more days,...
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider...
Drug regulator urges Pfizer to apply for COVID-19 vaccine...
New Delhi [India], July 6 (ANI): The Indian drug regulator has urged Pfizer twice in writing to apply for emergency...
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III...
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert...
DCGI's expert panel to review Phase III data of Covaxin today
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.